Research news
A new biological treatment could replace chemotherapy in patients with aggressive breast cancer
Today the results of the phase 2 CORALLEEN clinical trial, promoted by the international academic group SOLTI, have been presented. The study, publis1
Liver fibrosis could be treated with gold nanoparticles
Researchers at IDIBAPS, CIBERehd and ICFO implement gold nanoparticles and plasmonics to treat liver fibrosis in mice.
Scientists establish the safe dose of statins to use in combination with an antibiotic in the treatment of advanced cirrhosis
A study coordinated by researchers of the Clínic-IDIBAPS and published in The Lancet Gastroenterology & Hepatology establishes the safe dose of simva1
Researchers identify a molecular mechanism involved in neuronal degeneration caused by Huntington’s disease
Researchers from the IDIBAPS and the Institute of Neurosciences of the University of Barcelona (UBNeuro) described a mechanism, the increase of prote1
New technique to identify a cause that is common to diseases related to thrombotic microangiopathies for which there is a treatment
Researchers of the Hospital Clínic-IDIBAPS and the Josep Carreras Leukemia Research Institute have developed a new technique that allows detecting an1
Scientists discover cancer mutations in the unexplored area of genome
A consortium of researchers from the Cancer Research Center of Ontario and the Hospital for Sick Children of Toronto, the Hospital Clínic-IDIBAPS of1
Kick-off meeting of the Biomedicine International Training Research Program for excellent clinician-scientists (BITRECS)
The program provides beneficiaries - all of them brilliant postdoctoral professionals - with the opportunity to dedicate themselves fully to biomedic1
Researchers identify a group of genetic markers linked to the start of symptoms of Parkinson’s disease
Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro), Hospital Clínic and the IDIBAPS have identified a group of1
Researchers identify a new mechanism by which chronic inflammation progresses toward cancer
The continuous inflammation of some tissues, such as liver, pancreas or colon, is a known risk factor for the development of certain types of cancer.1